Introducing Minute17
Where thoughts light up.
Between minute fifteen and twenty1
Between minute fifteen and twenty, something happens for the cannabis smoker.
The cannabinoids and terpenes have completed their circuit through the body, fully engaging the
endocannabinoid system — a network of receptors that balance mood, focus, and calm.
The body enters what researchers describe as a cannabinoid plateau2 —
a physiological alignment where tension drops, perception sharpens, and breathing syncs with thought.
The human plane ascends beyond the anxiety cloud bank, and the mind arrives at the present moment.
This is what I call Minute17. Even as cannabis becomes legal in more states than not, we rarely talk about the moment of balance.
The focus is always on consumption — never on what happens next.
But the cannabinoid plateau is where the real story begins. That’s where the body steadies and attention settles.
It’s the physiological proof that calm and clarity are not opposites. And yet, it’s still taboo to talk about using cannabis as a performance-enhancing tool —
especially during the day. People use it like Adderall, but we’re not allowed to say that.
They use it to manage energy, to focus, to restock the patience reservoir that modern life constantly drains.
We call vapes discreet, but what we really mean is permitted only in silence.
We’ve accepted the object — but not the intent.
The conversation stops at the word "high" - that word still triggers shame in a large percnetage of cannabis consumers.
Used with intention, cannabis doesn’t cloud; it calibrates.
It restores rhythm, narrows the signal, and helps the mind move through the day with more presence and less panic. We’ve legalized the plant — now we need to legalize the experience. Minute17 is inspired from that physiological moment —
when the body’s chemistry finds rhythm and the mind finds visibility.
It’s not about intoxication; it’s about equilibrium.
A reminder that insight is measurable, and balance is an art. Minute17 lives at the intersection of data, design, and dialogue —
part atlas, part journal, part dinner table.
Every project here, from maps to essays, begins from the cannabinoid plateau —
the space where science meets self-awareness and stigma dissolves into curiosity. Minute¹⁷ expresses itself through four distinct but connected channels: Each vector lives under one sky — each a different way of showing what happens when thought lights up. Minute17 isn’t a celebration of consumption.
It’s an invitation to understand what happens when the body and mind align —
when the science of calm meets the art of thought. So take a breath. 1 Huestis, M. A. (2007). Human Cannabinoid Pharmacokinetics.
Journal of Analytical Toxicology, 31(1), 491–501. 2 Ohlsson, A., Lindgren, J.-E., Wahlen, A., Agurell, S., Hollister, L. E., & Gillespie, H. K. (1980).
Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking.
Clinical Pharmacology & Therapeutics, 28(3), 409–416.
Why It Matters
What Minute17 Is
The Vectors
Conversations from a Golden Gate vantage point — the East Berlin of Cannabis.
Over food and wood smoke (wink-wink-nudge-nudge), people gather to talk about what it really means to build an industry that began as resistance and is still finding its language of belonging.
The Invitation
Find your altitude.
Stay a while — on the cannabinoid plateau, where thoughts light up.
📚 References
— THC concentrations in plasma peak within 10 minutes of inhalation; subjective and physiological effects stabilize between 15–30 minutes post-intake, representing a plateau before gradual decline.
— Demonstrated the characteristic rise and stabilization (“plateau”) of THC levels following smoking, correlating with steady subjective effects.